Impact of rosuvastatin on pulse-wave velocity in men with HIV at moderate cardiovascular risk

被引：1

作者：

Trevillyan, Janine M. ^{[1
,2
]}

Dart, Anthony ^{[3
]}

Paul, Eldho ^{[4
]}

Dewar, Elizabeth M. ^{[3
]}

Hall, Victoria G. ^{[5
]}

Hoy, Jennifer F. ^{[6
,7
]}

机构：

[1] Austin Hlth, Dept Infect Dis, 145 Studley Rd, Heidelberg, Vic 3086, Australia

[2] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Infect Dis, Melbourne, Vic, Australia

[3] Alfred Hlth, Dept Cardiol, Heidelberg, Vic, Australia

[4] Monash Univ, Sch Publ Hlth & Prevent Med, ANZIC RC, Melbourne, Vic, Australia

[5] Peter MacCallum Canc Ctr, Dept Infect Dis, Melbourne, Vic, Australia

[6] Alfred Hlth, Dept Infect Dis, Melbourne, Vic, Australia

[7] Monash Univ, Melbourne, Vic, Australia

来源：

AIDS | 2024年 / 38卷 / 11期

基金：

英国医学研究理事会;

关键词：

ARTERIAL; STIFFNESS;

D O I：

10.1097/QAD.0000000000003930

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

This single-centre substudy of a double-blind, randomized, placebo-controlled trial aimed to determine the effect of 96 weeks of rosuvastatin on pulse wave velocity (PWV) in men (n = 55, 54 years) with HIV at moderate cardiovascular risk (Framingham risk score 10-15%). PWV increased in both rosuvastatin [0.54 m/s standard error of difference (SED) 0.26] and placebo [0.50 m/s (SED 0.26), P = 0.896] arms, leading to no difference in PWV at week 96 [rosuvastatin 9.40 m/s (SE 0.31); placebo 9.21 m/s (SE0.31), P = 0.676].

引用

页码：1722 / 1724

页数：3

共 50 条

[1] Impact of rosuvastatin on pulse wave velocity ( PWV) in men with HIV at moderate cardiovascular risk; a sub-study of a multinational, randomized, double blind, placebo-controlled trial
Hall, V.
Trevillyan, J. M.
Dart, A.
Dewar, L.
Hoy, J. F.
ANTIVIRAL THERAPY, 2020, 25 (03) : 43 - 43
[2] Impact of rosuvastatin on pulse wave velocity (PWV) in men with HIV at moderate cardiovascular risk; a sub-study of a multinational, randomized, double blind, placebo-controlled trial
Hall, V.
Trevillyan, J. M.
Dart, A.
Dewar, L.
Hoy, J. F.
ANTIVIRAL THERAPY, 2020, 25 : A43 - A43
[3] Pulse-wave velocity and cardiovascular risk factors in subjects with Helicobacter pylori infection
Adachi, K
Arima, N
Takashima, T
Miyaoka, Y
Yuki, M
Ono, M
Komazawa, Y
Kawamura, A
Fujishiro, H
Ishihara, S
Kinoshita, Y
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2003, 18 (07) : 771 - 777
[4] PULSE-WAVE VELOCITY AS AN INDEX OF AGING IN THE CARDIOVASCULAR SYSTEM
PAINE, RM
JOURNALS OF GERONTOLOGY, 1948, 3 (04): : 303 - 305
[5] INCREASED PULSE-WAVE VELOCITY AS A RISK FACTOR FOR LOWER URINARY TRACT SYMPTOMS IN MEN
Han, Ji-Yeon
Lee, Young-Suk
NEUROUROLOGY AND URODYNAMICS, 2017, 36 : S68 - S68
[6] Aortic pulse-wave velocity
Wilkinson, IB
Webb, DJ
Cockcroft, JR
LANCET, 1999, 354 (9194): : 1996 - 1997
[7] Aortic pulse-wave velocity versus pulse pressure and pulse-wave analysis
Lehmann, ED
LANCET, 2000, 355 (9201): : 412 - 412
[8] Pulse-Wave Velocity and Cardiovascular Risk Factors in the Beaver Dam Offspring Study (BOSS) Population
Zhong, Wenjun
Cruickshanks, Karen J.
Schubert, Carla
Javier Nieto, F.
Pankow, James S.
Acher, Charles W.
Baldwin, Clint T.
Huang, Guan-Hua
Klein, Barbara E.
Klein, Ronald
Miller, Michael B.
Tweed, Ted
CIRCULATION, 2009, 119 (10) : E338 - E338
[9] THE ASSOCIATION BETWEEN THE AORTIC PULSE-WAVE VELOCITY AND CARDIOVASCULAR-DISEASE RISK-FACTORS
NAMEKATA, T
MOORE, DE
HAYASHI, C
SUZUKI, K
HASEGAWA, M
HATANO, S
CIRCULATION, 1993, 87 (02) : 693 - 693
[10] Impact of rosuvastatin on atherosclerosis in people with HIV at moderate cardiovascular risk: a randomised, controlled trial
Trevillyan, Janine M.
Dart, Anthony
Paul, Eldho
Cavassini, Matthias
Fehr, Jan
Staehelin, Cornelia
Dewar, Elizabeth M.
Hoy, Jennifer F.
Calmy, Alexandra
AIDS, 2021, 35 (04) : 619 - 624

← 1 2 3 4 5 →